Aclaris Therapeutics (ACRS) Current Deferred Revenue (2024 - 2026)
Aclaris Therapeutics (ACRS) posted quarterly Current Deferred Revenue of $4.0 million for Q1 2026, up 2.16% year-over-year from $3.9 million in Q1 2025, and up 0.74% quarter-over-quarter from $3.9 million in Q4 2025.
Aclaris Therapeutics (ACRS) Current Deferred Revenue (2024 - 2026) Analysis & Trends
Aclaris Therapeutics' Current Deferred Revenue history runs 3 years deep, the most recent figure standing at $4.0 million for Q1 2026.
- In Q1 2026, Current Deferred Revenue rose 2.16% year-over-year to $4.0 million; the TTM figure through Mar 2026 stood at $4.0 million (up 2.16% YoY), while the FY2025 annual figure was $3.9 million, up 1.36% from the prior year.
- Current Deferred Revenue for Q1 2026 stood at $4.0 million, up from $3.9 million in the prior quarter.
- The five-year high for Current Deferred Revenue was $25.8 million in Q2 2024, with the low at $3.8 million in Q3 2024.
- The 3-year median for Current Deferred Revenue is $3.9 million (2025), against an average of $6.6 million.
- Peak annual rise in Current Deferred Revenue reached 4.25% in 2025, while the deepest fall reached 84.83% in 2025.
- Aclaris Therapeutics' Current Deferred Revenue stood at $3.9 million in 2024, then gained by 1.36% to $3.9 million in 2025, then rose by 0.74% to $4.0 million in 2026.
- Business Quant data shows ACRS's Current Deferred Revenue at $4.0 million in Q1 2026, $3.9 million in Q4 2025, and $3.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Aclaris Therapeutics | 808.18 Mn | 716.63 Mn | 1.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.98 Mn |
| Mar 31, 2026 | 3.97 Mn |
| Dec 31, 2025 | 3.94 Mn |
| Sep 30, 2025 | 3.93 Mn |
| Jun 30, 2025 | 3.91 Mn |
| Mar 31, 2025 | 3.89 Mn |
| Dec 31, 2024 | 3.89 Mn |
| Sep 30, 2024 | 3.77 Mn |
| Jun 30, 2024 | 25.80 Mn |